Dexrazoxane in anthracycline extravasation.
Langer
S W
SW
Sehested
M
M
Jensen
P B
PB
Buter
J
J
Giaccone
G
G
D000818:Animals; D018943:Anthracyclines / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002317:Cardiovascular Agents / Q000627:therapeutic use; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D009336:Necrosis; D011929:Razoxane / Q000627:therapeutic use*
D018943:Anthracyclines; D000970:Antineoplastic Agents; D002317:Cardiovascular Agents; D011929:Razoxane